SCHEMBL4533276

SCHEMBL4533276

CC(C)CC(C)(C)OS(=O)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.32
GRM2 Q14416 1/20 0.31
GRM3 Q14832 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL27903544 0.83 MAPK1 (0.32)
SCHEMBL20051699 0.78 CA2 (0.36) MMP8
SCHEMBL22348789 0.76
SCHEMBL777817 0.73 ALDH1A1 (0.39)
SCHEMBL22333722 0.72
SCHEMBL9743122 0.72 CA2 (0.39)
SCHEMBL15936826 0.71 CA2 (0.30)
SCHEMBL6417340 0.71 LMNA (0.31)
SCHEMBL17456457 0.71 ALDH1A1 (0.38)
SCHEMBL4800599 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702616-B2 Metal complexes and dishwashing detergents containing them HENKEL AG & CO. KGAA (DE) 2023-07-18 US disclosed
US-20210040309-A1 LOW MOLECULAR WEIGHT DRY POWDER POLYMER FOR USE AS PAPER-MAKING DRY STRENGTH AGENT ECOLAB USA INC. (US) 2021-02-11 US disclosed
US-10857280-B2 Methods of synthesizing hydrous zirconium oxide and other oxides FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) 2020-12-08 US disclosed
US-20130190168-A1 Methods Of Synthesizing Hydrous Zirconium Oxide And Other Oxides FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) 2013-07-25 US disclosed
WO-2012057941-A2 METHODS OF SYNTHESIZING HYDROUS ZIRCONIUM OXIDE AND OTHER OXIDES FRESENIUS MEDICAL CARE HOLDINGS, INC. (US) 2012-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210040309-A1 LOW MOLECULAR WEIGHT DRY POWDER POLYMER FOR USE AS PAPER-MAKING DRY STRENGTH AGENT ACP1, PWWP2B, MACF1 MMP8 3755/4885GRM2 896/4885GRM3 1266/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.